Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS: ACUR · Delayed Price · USD
0.0200
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Acura Pharmaceuticals Market Cap
Acura Pharmaceuticals has a market cap or net worth of $1.32 million as of July 22, 2024. Its market cap has decreased by -91.48% in one year.
Market Cap
1.32M
Enterprise Value
n/a
1-Year Change
-91.48%
Ranking
n/a
Category
Stock Price
$0.02
Market Cap Chart
Since December 1, 1998, Acura Pharmaceuticals's market cap has decreased from $16.60M to $1.32M, a decrease of -92.05%. That is a compound annual growth rate of -10.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 2, 2022 | 3.30M | -89.85% |
Dec 31, 2021 | 32.50M | 622.22% |
Dec 31, 2020 | 4.50M | -8.16% |
Dec 31, 2019 | 4.90M | 104.17% |
Dec 31, 2018 | 2.40M | -71.08% |
Dec 29, 2017 | 8.30M | -8.79% |
Dec 30, 2016 | 9.10M | -69.15% |
Dec 31, 2015 | 29.50M | 34.09% |
Dec 31, 2014 | 22.00M | -72.74% |
Dec 31, 2013 | 80.70M | -20.73% |
Dec 31, 2012 | 101.80M | -35.65% |
Dec 30, 2011 | 158.20M | 8.88% |
Dec 31, 2010 | 145.30M | -36.55% |
Dec 31, 2009 | 229.00M | -26.98% |
Dec 31, 2008 | 313.60M | 20.38% |
Dec 31, 2007 | 260.50M | 6.50% |
Dec 29, 2006 | 244.60M | 165.58% |
Dec 30, 2005 | 92.10M | 1,051.25% |
Dec 31, 2004 | 8.00M | -17.53% |
Dec 31, 2003 | 9.70M | -30.71% |
Dec 31, 2002 | 14.00M | -52.38% |
Dec 31, 2001 | 29.40M | 180.00% |
Dec 29, 2000 | 10.50M | -22.22% |
Dec 31, 1999 | 13.50M | -30.05% |
Dec 31, 1998 | 19.30M | 16.27% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 814.94B |
Novo Nordisk | 579.91B |
UnitedHealth Group | 520.32B |
Johnson & Johnson | 372.29B |
Merck & Co. | 318.55B |
AbbVie | 304.29B |
AstraZeneca | 244.04B |
Novartis AG | 207.64B |